So this ties into the Amarex CEO who worked for Gilead and the stop on the trial with Remdesivir, a Gilead drug, at the beginning of Covid19. Gilead knew if Leronlimab was given approval on Covid19 it could be used to treat HIV and the other way around. So Amarex messes with our HIV numbers, screws with our CD12 trial and keeps Leronlimab off the shelves for two years. Just a theory, but as the church lady used to say, "how convenient".